The Medipattern Corporation
TSX VENTURE : MKI

The Medipattern Corporation

October 15, 2008 06:30 ET

More Effective Breast Lesion Tracking With Medipattern's B-CAD® Versions 1.3/2.3

Catholic Medical Center finds B-CAD saves time, improves consistency, adds revenue

TORONTO, ONTARIO--(Marketwire - Oct. 15, 2008) -

Attention: Business/Financial Editors

The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, introduces enhancements to its award-winning B-CAD breast imaging computer aided detection (CAD) solution. B-CAD Versions 1.3 and 2.3 bring numerous enhancements to Medipattern's comprehensive solution for breast ultrasound imaging, which combines CAD with structured digital reporting. B-CAD increases efficiency and productivity to help the medical enterprise be more effective in day-to-day practice.

These versions have been installed in partner sites, including the Catholic Medical Center (CMC) in Manchester, New Hampshire, to validate the expanded workflow of versions 1.3 / 2.3 in many environments as part of Medipattern's Beta Test Phase. The Company expects to roll out the new products during the fourth quarter of 2008. Version 1.3 is available for sale in the United Sates and version 2.3 is available globally. The global versions are available in Chinese, French, German, Italian, Spanish as well as English. "B-CAD uses the power of CAD to find the edge of the lesion and characterize it using the American College of Radiology BI-RADS® lexicon and then B-CAD takes it all to a whole new digital level giving the sonographer the ability to make a completely digital worksheet that is sent to PACS (Picture Archiving and Communication System) and included in the electronic record with the images. Now the radiologist reads the information from the worksheet on the same workstation used to view the images. Everything is digital and all of the information is consistent. And because B-CAD renders a second opinion we have been reimbursed for the procedure," comments Michael Cloutier, Manager, Technical Services and Imaging Informatics at CMC. "B-CAD is a win, win, win. It's great for the sonographer, radiologist and for hospital administrators like me."

"Most women's health practices use breast ultrasound imaging everyday. Ultrasound is a great diagnostic tool. It is non-invasive, non-harmful and gives great snapshot images. But these snapshots are just image frames that are not in context to the rest of the breast. They have to be documented and referenced to include image location, patient information, and other image characteristics for them to be interpreted by radiologists. Even though ultrasound images are digital, the complete process is not fully digital. The only way to note the information is to write it down, which can add an average of eight to ten minutes per patient to the sonographer's workload. All of the information then has to be presented to the radiologist to review when interpreting the case. This means that the radiologist refers to a hand written sonographer's worksheet while reading digital images. Although these worksheets may be 'scanned' into the PACS system, it still remains a cumbersome process. The notes can vary from one sonographer to another and these factors also add time to the radiologist's workload. Medipattern addresses all of these issues with the B-CAD system," concluded Mr. Cloutier.

CMC intensified its services for Women's Health when it opened a Comprehensive Breast Care Center in 2005. CMC was the first hospital to offer digital mammography in New Hampshire as well as other leading edge detection, diagnosis and treatment procedures. Other hospitals benefit from the experience that CMC shares with these technologies making the transition to digital and CAD more efficient for the whole network.

"Breast ultrasound is used to track patients; B-CAD helps sonographers and radiologists follow lesions more easily with standardized reporting. Sonographers can view the prior exam in B-CAD, and then take all of the patient notes, describe images, and measurements in a digital format. This digital worksheet can be sent to radiologists to review in B-CAD or on their own PACS workstations. B-CAD is also very helpful to radiologists who perform their own scanning, enabling them to view prior images, note details on the current exam, score lesion severity and finalize reporting quickly and efficiently," states Jeff Collins, CEO of Medipattern. "The enhancement to B-CAD offers greater connectivity to PACS through DICOM query / retrieve to view prior breast ultrasound studies while performing the current exam and the ability to send reports to PACS in DICOM (Digital Imaging and Communications in Medicine) format."

"The fusion of text and image information in the same consistent digital workflow provides a unified process that brings CAD beyond marking areas of an image or measuring image features. B-CAD organizes the process, from reviewing prior information to disseminating current status in a thorough and organized manner. B-CAD is now the catalyst that enables our customers to B-more efficient, B-more productive and B-more effective."

"All of the sonographers and reading radiologists at CMC have actively taken part in our market focus research, product definition and testing phases. B-CAD works hand in hand with sonographers and physicians to streamline workflow and create comprehensive, standardized and fully digital documentation. We are delighted to have CMC as our partners," concluded Mr. Collins.

Product Description:

B-CAD v1.3, available in the United States, and B-CAD v2.3, available globally, are the first breast ultrasound computer-aided detection (CAD) tools to provide advanced decision-making support for lesion analysis. Using B-CAD, radiologists are able to consistently document notes, patient history, and lesion information, resulting in a thorough diagnosis and efficient communication. B-CAD is part of a comprehensive offering that provides radiologists and sonographers with the time-saving tools they need to work effectively while maintaining consistent communication across the enterprise. B-CAD makes your practice more efficient, more productive and more effective.



Upcoming Events:

Medipattern will participate in the following events:

- Society of Diagnostic Medical Sonography (SDMS) Annual Meeting
October 16 to 19 Foxwoods Resort Casino, CT at the GE booth
- China Medical Exposition
October 20 to 24 Beijing, PRC at the BJEW booth
- Journees Francaises Radiologie
October 24 to 28 Paris, France at the AG Medical Booth
- Radiological Society of North America (RSNA) Annual Meeting
November 30 to December 5 Chicago, IL at the Medipattern Booth and at
the GE Booth


The Medipattern Corporation

Medipattern® is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the company's website at: www.medipattern.com.

Cadenza™ and B-CADmri™ are trademarks of The Medipattern Corporation.
B-CAD® and Medipattern® are a registered mark of The Medipattern Corporation. BI-RADS® is a registered trademark of the American College of Radiology.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved of the contents of this release.

Contact Information